ATA309588A - Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform - Google Patents

Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform

Info

Publication number
ATA309588A
ATA309588A AT0309588A AT309588A ATA309588A AT A309588 A ATA309588 A AT A309588A AT 0309588 A AT0309588 A AT 0309588A AT 309588 A AT309588 A AT 309588A AT A309588 A ATA309588 A AT A309588A
Authority
AT
Austria
Prior art keywords
crystal shape
ciclosporin
new
production
pharmaceutical composition
Prior art date
Application number
AT0309588A
Other languages
English (en)
Other versions
AT403163B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA309588A publication Critical patent/ATA309588A/de
Application granted granted Critical
Publication of AT403163B publication Critical patent/AT403163B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT0309588A 1987-12-21 1988-12-20 Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform AT403163B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28

Publications (2)

Publication Number Publication Date
ATA309588A true ATA309588A (de) 1997-04-15
AT403163B AT403163B (de) 1997-11-25

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0309588A AT403163B (de) 1987-12-21 1988-12-20 Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform

Country Status (27)

Country Link
JP (1) JPH0791316B2 (de)
KR (1) KR100188305B1 (de)
AT (1) AT403163B (de)
AU (1) AU626274B2 (de)
BE (1) BE1002665A4 (de)
CA (1) CA1341396C (de)
CH (1) CH677926A5 (de)
CY (1) CY1799A (de)
DE (1) DE3843054C2 (de)
DK (1) DK175220B1 (de)
ES (1) ES2012580A6 (de)
FI (1) FI89065C (de)
FR (1) FR2624863B1 (de)
GB (1) GB2211848B (de)
GR (1) GR1002486B (de)
HK (1) HK102894A (de)
HU (1) HU203564B (de)
IE (1) IE62006B1 (de)
IL (1) IL88719A0 (de)
IT (1) IT1235356B (de)
LU (1) LU87409A1 (de)
MY (1) MY103943A (de)
NL (1) NL195096C (de)
NO (1) NO177228C (de)
NZ (1) NZ227384A (de)
SE (1) SE503174C2 (de)
SG (1) SG99494G (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
ES2177652T3 (es) 1994-11-03 2002-12-16 Novartis Ag Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion.
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
KR20050084502A (ko) 1997-01-30 2005-08-26 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 a 함유 제약 조성물
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CN100548271C (zh) 2004-01-20 2009-10-14 阿勒根公司 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
BR112013030554B1 (pt) * 2011-05-27 2020-12-15 Allergan, Inc. Forma cristalina de ciclosporina a, métodos de preparação e métodos para uso da mesma
RU2641963C2 (ru) * 2011-11-15 2018-01-23 Аллерган, Инк. Взвеси циклоспорина а формы 2
US20130123194A1 (en) * 2011-11-15 2013-05-16 Allergan, Inc. Autoclavable suspensions of cyclosporin a form 2
CA2856034C (en) * 2011-11-15 2017-12-12 Allergan, Inc. Cyclosporin a form 2 and method of making same
US8785394B2 (en) * 2011-11-15 2014-07-22 Allergan, Inc. Sustained action formulation of cyclosporin form 2
TW202430537A (zh) * 2022-10-20 2024-08-01 日商中外製藥股份有限公司 環狀胜肽的結晶的製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (de) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
NZ227384A (en) 1991-09-25
DK705488A (da) 1989-06-22
CH677926A5 (de) 1991-07-15
LU87409A1 (fr) 1989-07-07
NL195096C (nl) 2004-02-09
DK175220B1 (da) 2004-07-12
JPH01211598A (ja) 1989-08-24
FR2624863A1 (fr) 1989-06-23
IT8848690A0 (it) 1988-12-20
SE8804570D0 (sv) 1988-12-19
KR100188305B1 (ko) 1999-06-01
BE1002665A4 (fr) 1991-04-30
GR1002486B (el) 1996-12-09
GR880100850A (el) 1994-03-31
MY103943A (en) 1993-10-30
HK102894A (en) 1994-09-30
IT1235356B (it) 1992-06-30
CY1799A (en) 1995-02-17
CA1341396C (en) 2002-11-05
NL8803125A (nl) 1989-07-17
AT403163B (de) 1997-11-25
ES2012580A6 (es) 1990-04-01
JPH0791316B2 (ja) 1995-10-04
FR2624863B1 (fr) 1991-04-26
NO885625D0 (no) 1988-12-19
GB2211848B (en) 1991-11-06
FI885869A0 (fi) 1988-12-19
FI89065C (fi) 1993-09-30
SE8804570L (sv) 1989-06-22
DE3843054A1 (de) 1989-07-27
AU626274B2 (en) 1992-07-30
DK705488D0 (da) 1988-12-19
NO885625L (no) 1989-06-22
SE503174C2 (sv) 1996-04-15
IL88719A0 (en) 1989-07-31
IE62006B1 (en) 1994-12-14
AU2705588A (en) 1989-06-22
FI885869L (fi) 1989-06-22
FI89065B (fi) 1993-04-30
IE883779L (en) 1989-06-21
KR890009975A (ko) 1989-08-05
SG99494G (en) 1994-10-28
HUT49893A (en) 1989-11-28
NO177228B (no) 1995-05-02
DE3843054C2 (de) 2003-08-21
NO177228C (no) 1995-08-09
HU203564B (en) 1991-08-28
GB8829556D0 (en) 1989-02-08
GB2211848A (en) 1989-07-12

Similar Documents

Publication Publication Date Title
PT82169B (de) Neue sulfonylaminoathylverbindungen diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3381680D1 (de) 1,4-dihydropyridincarbonsaeure-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT82789B (de) Neue 2-arylmidazole diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3850800D1 (de) Supraleitendes Material und Verfahren zu dessen Herstellung.
PT80476A (de) Neue aminotetralinderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE69033534D1 (de) Xylit enthaltende hartbonbons und verfahren zu ihrer herstellung
ATA195788A (de) Tripeptide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
PT85335A (de) Neue benzolsulfonamido-indanylverbindungen diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE58907887D1 (de) Kohlensäureester von Polysacchariden und Verfahren zu ihrer Herstellung.
DE3887390D1 (de) Lichtschutz-Schirmstruktur und Verfahren zu ihrer Herstellung.
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
GB8829556D0 (en) New cyclosporin crystal form processes for its production pharmaceutical compositions containing it and its use
DE68927949D1 (de) 3,9-Diphosphaspiroundecane und Verfahren zur Herstellung von 3,9-Diphosphaspiroundecanen
ATE143010T1 (de) Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE68922538D1 (de) Fäserchen enthaltender Streifen und Verfahren zu dessen Herstellung.
DE3674582D1 (de) (s)-(-)-1-propyl-2',6'-pipecoloxylidid-hydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
DE3852963D1 (de) Kristallines menschliches Proinsulin und Verfahren zu dessen Herstellung.
DE3886856D1 (de) Hitzebeständige Materialien und Verfahren zu ihrer Herstellung.
DE68900485D1 (de) Derivate von phenoxyalkylcarbonsauere und verfahren zu ihrer herstellung.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE3670635D1 (de) Neue benzisoselenazolonyl-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE68915094D1 (de) Benzofuranverbindungen, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische und kosmetische Zusammenstellungen und Verwendung dieser Zusammenstellungen.
ATA267788A (de) Verfahren zur herstellung von polynucleotiden, so erhaltene produkte und diese enthaltende pharmazeutische zusammensetzungen
DE3682370D1 (de) 3-aminocarbonyl-1,4-dihydropyridin-5-carboxylsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zusammensetzungen.
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELA Expired due to lapse of time